VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $581,000 | -12.6% | 25,000 | -40.1% | 0.28% | +80.3% |
| Q1 2018 | $665,000 | -4.5% | 41,750 | +24.6% | 0.16% | -0.6% |
| Q4 2017 | $696,000 | -59.8% | 33,500 | -66.5% | 0.16% | -70.5% |
| Q2 2017 | $1,730,000 | +526.8% | 100,000 | +300.0% | 0.54% | +654.9% |
| Q1 2017 | $276,000 | -95.5% | 25,000 | -94.1% | 0.07% | -97.5% |
| Q4 2016 | $6,171,000 | +1431.3% | 425,000 | +2025.0% | 2.88% | +1467.4% |
| Q2 2016 | $403,000 | -52.1% | 20,000 | -37.5% | 0.18% | -4.2% |
| Q1 2016 | $842,000 | -83.4% | 32,000 | -36.0% | 0.19% | -88.2% |
| Q4 2015 | $5,083,000 | +2035.7% | 50,000 | +4559.8% | 1.63% | +3975.0% |
| Q2 2015 | $238,000 | – | 1,073 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |